Skip to main content
. 2021 Aug 17;21:826. doi: 10.1186/s12913-021-06848-9

Table 1.

Baseline sample characteristics by completion of post-hospital follow-up provider visits within 7-days of discharge

POSH TPOSH Non-POSH No Visit Total Max Std Diff
n = 56,383
(26.4%)
n = 9009
(4.2%)
n = 69,997
(32.8%)
n = 78,124
(36.6%)
n = 213,513 Not
Wgtd
Wgtd
Socio-demographics
 Age 66.5 (16.4) 69.5 (16.2) 58.9 (17.8) 57.8 (18.6) 60.9 (18.1) 0.68 0.05
 Female 27,203 (48.2%) 4857 (53.9%) 36,903 (52.7%) 45,197 (57.9%) 114,160 (53.5%) 0.10 0.01
Race/Ethnicity
 Asian 5042 (8.9%) 721 (8%) 6432 (9.2%) 6459 (8.3%) 18,654 (8.7%) 0.01 0.00
 Black 6440 (11.4%) 1446 (16.1%) 7434 (10.6%) 9146 (11.7%) 24,466 (11.5%) 0.05 0.01
 Hispanic 18,788 (33.3%) 2517 (27.9%) 24,815 (35.5%) 28,760 (36.8%) 74,880 (35.1%) 0.09 0.01
 Other 1041 (1.8%) 155 (1.7%) 1385 (2%) 1554 (2%) 4135 (1.9%) 0.00 0.00
 White 25,072 (44.5%) 4170 (46.3%) 29,931 (42.8%) 32,205 (41.2%) 91,378 (42.8%) 0.05 0.01
Marital status: Partnered 32,842 (58.2%) 4622 (51.3%) 42,151 (60.2%) 44,166 (56.5%) 123,781 (58%) 0.09 0.01
Education: < College 41,216 (73.1%) 6504 (72.2%) 50,048 (71.5%) 56,640 (72.5%) 154,370 (72.3%) 0.09 0.05
Household income: >$20,000 48,602 (86.2%) 7667 (85.1%) 60,477 (86.4%) 67,187 (86.0%) 184,048 (86.2%) 0.15 0.06
Spoken language: English 48,993 (86.9%) 8108 (90%) 62,222 (88.9%) 69,453 (88.9%) 188,776 (88.4%) 0.03 0.02
Insurance typea
 Commercial/private pay 21,503 (38.1%) 2772 (30.8%) 37,651 (53.8%) 43,070 (55.1%) 104,996 (49.2%) 0.24 0.02
 Dual 3215 (5.7%) 591 (6.6%) 2450 (3.5%) 2907 (3.7%) 9163 (4.3%) 0.03 0.01
 Medicaid 2493 (4.4%) 392 (4.4%) 3838 (5.5%) 4754 (6.1%) 11,477 (5.4%) 0.02 0.01
 Medicare 29,160 (51.7%) 5250 (58.3%) 26,035 (37.2%) 27,330 (35%) 87,775 (41.1%) 0.23 0.02
Received medical financial assistance in prior year 4590 (8.1%) 941 (10.4%) 5163 (7.4%) 5035 (6.4%) 15,729 (7.4%) 0.04 0.00
Health and Behavior Before Hospitalization
 Clinic no show rate (at least once) 34,084 (60.5%) 6185 (68.7%) 43,594 (62.3%) 47,297 (60.5%) 131,160 (61.4%) 0.08 0.01
 Charlson comorbidity indexb 4.7 (3.08) 5.5 (3.14) 3.8 (2.99) 3.4 (2.94) 4.0 (3.07) 0.68 0.03
  Myocardial infarction 9635 (17.1%) 1727 (19.2%) 7030 (10%) 6703 (8.6%) 25,095 (11.8%)
  Congestive heart failure 13,396 (23.8%) 2684 (29.8%) 9295 (13.3%) 8613 (11%) 33,988 (15.9%)
  Peripheral vascular disease 26,973 (47.8%) 5236 (58.1%) 22,050 (31.5%) 22,215 (28.4%) 76,474 (35.8%)
  Cerebrovascular disease 12,175 (21.6%) 2358 (26.2%) 9105 (13%) 9833 (12.6%) 33,471 (15.7%)
  Dementia 3536 (6.3%) 1134 (12.6%) 1940 (2.8%) 3357 (4.3%) 9967 (4.7%)
  Rheumatic disease 3937 (7%) 710 (7.9%) 3692 (5.3%) 3711 (4.8%) 12,050 (5.6%)
  Peptic ulcer disease 3779 (6.7%) 687 (7.6%) 3094 (4.4%) 3296 (4.2%) 10,856 (5.1%)
  Mild liver disease 8727 (15.5%) 1499 (16.6%) 9095 (13%) 9301 (11.9%) 28,622 (13.4%)
  Moderate or severe liver disease 1355 (2.4%) 236 (2.6%) 890 (1.3%) 837 (1.1%) 3318 (1.6%)
  Diabetes without chronic complication 7821 (13.9%) 1159 (12.9%) 8766 (12.5%) 9464 (12.1%) 27,210 (12.7%)
  Diabetes with chronic complication 18,284 (32.4%) 3201 (35.5%) 14,142 (20.2%) 12,878 (16.5%) 48,505 (22.7%)
  Hemiplegia or paraplegia 2909 (5.2%) 740 (8.2%) 2211 (3.2%) 2721 (3.5%) 8581 (4%)
  Renal disease 20,089 (35.6%) 3776 (41.9%) 14,696 (21%) 14,609 (18.7%) 53,170 (24.9%)
  Any malignancy (lymphomas, leukemias etc) 8825 (15.7%) 1788 (19.8%) 11,963 (17.1%) 9563 (12.2%) 32,139 (15.1%)
  Metastatic solid tumor 3343 (5.9%) 830 (9.2%) 4578 (6.5%) 3006 (3.8%) 11,757 (5.5%)
  AIDS/HIV 236 (0.4%) 51 (0.6%) 281 (0.4%) 244 (0.3%) 812 (0.4%)
 Frailty index 8.8 (6.65) 11.1 (8.35) 6.1 (6.05) 5.7 (6.44) 6.9 (6.65)
  Low risk < 5 18,052 (32%) 2310 (25.6%) 37,893 (54.1%) 46,855 (60%) 105,110 (49.2%) 0.34 0.01
  Intermediate risk 5–14 29,643 (52.6%) 4366 (48.5%) 26,225 (37.5%) 24,610 (31.5%) 84,844 (39.7%) 0.21 0.01
  High Risk 15+ 8688 (15.4%) 2333 (25.9%) 5879 (8.4%) 6659 (8.5%) 23,559 (11%) 0.17 0.01

Values are presented as either mean (SD) or n (column %), unless otherwise indicated

POSH Post-hospital follow-up clinic visit, TPOSH Post-hospital follow-up telephone visit, nonPOSH visit not related to post-hospital follow-up

Wgtd Weighted maximum standardized differences across groups

a Missingness < 0.1

bWeighting only done on index, not individual conditions